Common Stock, Shares, Outstanding of SUTRO BIOPHARMA, INC. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
SUTRO BIOPHARMA, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • SUTRO BIOPHARMA, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 85,101,749, a 3.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

SUTRO BIOPHARMA, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 85,101,749 +2,706,399 +3.3% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 84,720,047 +2,858,463 +3.5% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 84,349,041 +21,892,495 +35% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 82,526,430 +21,516,601 +35% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 82,395,350 +21,494,646 +35% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 81,861,584 +21,390,543 +35% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 62,456,546 +2,294,745 +3.8% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 61,009,829 +3,510,288 +6.1% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 60,900,704 +6,269,344 +11% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 60,471,041 +11,796,809 +24% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 60,161,801 +13,234,942 +28% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 57,499,541 +11,172,410 +24% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 54,631,360 +8,370,300 +18% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 48,674,232 +2,532,778 +5.5% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 46,926,859 +823,253 +1.8% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 46,327,131 +575,015 +1.3% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 46,261,060 +8,168,082 +21% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 46,141,454 +10,262,526 +29% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 46,103,606 +22,876,185 +98% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 45,752,116 +22,653,147 +98% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 38,092,978 +15,002,976 +65% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 35,878,928 +12,951,725 +56% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 23,227,421 +301,980 +1.3% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 23,098,969 +250,785 +1.1% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 23,090,002 +22,604,905 +4660% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 22,927,203 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 22,925,441 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 22,848,184 +22,382,854 +4810% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 485,097 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q4 2017 465,330 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.